PAA 4.88% 19.5¢ pharmaust limited

Clinical Trials, page-301

  1. 628 Posts.
    lightbulb Created with Sketch. 111
    Eli Lilly have at least one repurposed drug in Phase 3 trial to treat COVID : https://investor.lilly.com/news-releases/news-release-details/lilly-begins-phase-3-clinical-trial-baricitinib-hospitalized

    Baricitinib is owned by Incyte, which popped about $4B USD in MC on the news its product was being trialled. I would expect a similar pop for PAA if MPL gets to Phase 3, say $6B AUD. So my rough calculation is PAA gets to $20 a share BEFORE MPLs effectiveness is proven (or not).

    THEN, I’ll know the pressure the holders of 2 million shares are feeling this weekend.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.010(4.88%)
Mkt cap ! $77.20M
Open High Low Value Volume
19.5¢ 19.5¢ 18.8¢ $342.8K 1.779M

Buyers (Bids)

No. Vol. Price($)
2 52999 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 421000 3
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.